The 20 Best Neuroblastoma Doctors Near Me in District of Columbia, US

Holly Meany, MD, is a pediatric oncologist and director of the Solid Tumor Program at Children’s National Hospital. She also serves as an associate professor of pediatrics at George Washington University. Dr. Meany is dedicated to finding better treatments for children with cancer through research and clinical care. Her work focuses on developing new therapies for pediatric solid tumors. She designs and leads early-phase clinical trials to test promising treatments and understand how they work in children. Dr. Meany has played a key role in several national studies, including large trials for neuroblastoma, a type of childhood cancer. She recently led an international study for children with newly diagnosed non-high-risk neuroblastoma and is currently helping to develop the next high-risk neuroblastoma trial, both through the Children’s Oncology Group. Dr. Meany is also exploring innovative approaches like immunotherapy—using the body’s own immune system to fight cancer. She has led international studies using specialized T cells to treat patients with relapsed solid tumors and is now working on combining these novel T cells with CAR T-cell therapy for children with relapsed cancers. In addition to her research, Dr. Meany is passionate about training the next generation of pediatric cancer specialists. As director of the Pediatric Hematology-Oncology Fellowship Program at Children’s National, she mentors and supports future leaders in the field. Dr. Meany is rated as a Distinguished provider by MediFind in the treatment of Neuroblastoma. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Neuroblastoma, Hereditary Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Osteosarcoma, and Mastoidectomy. Dr. Meany is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2006 and Pediatrics: American Board Of Pediatrics, 2003.

Jeffrey Dome, MD, PhD, is senior vice president of the Cancer and Blood Disorders Center at Children’s National Hospital in Washington, D.C. He is professor of pediatrics at the George Washington University School of Medicine and Health Sciences and the Thomas Willson and Lenore Williams McKnew professor of pediatric oncology. Dr. Dome received his medical degree from the University of Pennsylvania School of Medicine and PhD degree in medicine from Erasmus University in Rotterdam. He completed a residency in pediatrics at Yale-New Haven Hospital and completed a fellowship in pediatric hematology/oncology at Johns Hopkins Hospital. After fellowship, Dr. Dome was a faculty member at St. Jude Children’s Research Hospital before joining Children’s National in 2006. Dr. Dome is an internationally recognized expert on pediatric solid tumors, with an emphasis on kidney tumors and sarcomas. He chaired the Children’s Oncology Group (COG) Renal Tumor Committee for more than a decade. He is presently on the Scientific Council of the COG, the editorial board of Pediatric Blood and Cancer, and is past chair of the American Board of Pediatrics Subboard of Hematology/Oncology. Dr. Dome serves on numerous medical advisory boards for cancer foundations and currently is the North American Continental President of the International Society of Pediatric Oncology (SIOP). He has authored more than 200 articles, books, letters and chapters on pediatric cancer. Dr. Dome is rated as an Advanced provider by MediFind in the treatment of Neuroblastoma. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Rhabdoid Tumor, Denys-Drash Syndrome (DDS), Adult Soft Tissue Sarcoma, Nephrectomy, and Bone Marrow Aspiration. Dr. Dome is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 1998.

Jeffrey Toretsky is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Toretsky is rated as an Advanced provider by MediFind in the treatment of Neuroblastoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Ewing Sarcoma, Osteosarcoma, Adult Soft Tissue Sarcoma, Rhabdomyosarcoma, and Bone Marrow Aspiration.

Catherine Bollard is a Pediatrics provider practicing medicine in Washington, Washington, D.c.. Dr. Bollard is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Hodgkin Lymphoma, Graft Versus Host Disease (GvHD), Leukemia, Acute Lymphoblastic Leukemia (ALL), and Bone Marrow Transplant.

Brian R. Rood, MD, is the director of clinical neuro-oncology and the medical director of the Brain Tumor Institute at Children's National Hospital. Dr. Rood is also a principal investigator in the Center for Cancer and Immunology Research at Children's National Research Institute and a professor of pediatrics at the George Washington University School of Medicine and Health Sciences and adjunct professor at the Fralin Biomedical Research Institute at Virginia Tech. He received a Bachelor of Arts in English Literature from The Pennsylvania State University and completed medical school at Jefferson Medical College. He completed his pediatric residency training at the University of Vermont. Dr. Rood received his pediatric hematology/oncology training at Children's National. He joined the faculty of Children’s National in 2002 after completing a fellowship in pediatric hematology/oncology, as well as a research fellowship in the molecular biology of brain tumors, both at Children’s National and Children’s National Research Institute. Currently, Dr. Rood’s research focuses on the application of proteomics in cancer biology investigation, neoantigen identification and biomarker development. He has also been studying the contribution of germline microsatellite genotypes to pediatric brain tumor predisposition. He currently serves as the executive co-chair of the Children’s Brain Tumor Network, an international consortium of 28 institutions that maintains the world’s largest pediatric brain tumor tissue and data repository, which are freely provided to the research community to support the development of groundbreaking clinical trials through data-driven precision medicine. Dr. Rood has two children. His favorite pastimes include designing and building furniture, sailing, reading, and playing the mandolin. Dr. Rood is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Medulloblastoma, Embryonal Tumor with Multilayered Rosettes, Glioma, and Diffuse Midline Glioma H3 K27M-Mutant. Dr. Rood is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2002 and Pediatrics: American Board Of Pediatrics, 1998.

Luca Szalontay is a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. She has been practicing medicine for over 17 years. Dr. Szalontay is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Glioma, Diffuse Midline Glioma H3 K27M-Mutant, Medulloblastoma, and Brain Stem Cancer. Dr. Szalontay is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2021 and Pediatrics: American Board Of Pediatrics, 2015.

Nita L. Seibel, MD, is a board-certified pediatrician and pediatric hematologist-oncologist. After graduating from the Ohio State University College of Medicine in 1988, she completed her internship and residency at the Ohio State University Children’s Hospital in 1984. Dr. Seibel completed a fellowship in pediatric hematology-oncology at the Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health in 1987. She joined the faculty of Children's National Hospital in 1988 and is a professor of pediatrics at the George Washington University School of Medicine & Health Sciences. While at Children's National, Dr. Seibel has served for over 15 years on the Institutional Review Board, as Director of the Hematology/Oncology Training Program for nine years and as Principal Investigator for Children's Oncology Group. Dr. Seibel has chaired numerous studies for the Children’s Oncology Group including chairing the Phase I Data Safety Monitoring Committee and served as vice-chair for Phase I agents. Dr. Seibel was also a member of the National Wilms Tumor Study and later the COG Renal Tumor Committee. Dr. Seibel's areas of special interest are: Wilms tumor, bone tumors, ALL, and adolescent and young adult oncology as well as late effects. She also has a special interest in Acute Lymphoblastic Leukemia in adolescents and young adults and anti-fungal agents. Dr. Seibel is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Adult Soft Tissue Sarcoma, and Infantile Neutropenia. Dr. Seibel is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 1987 and Pediatrics: American Board Of Pediatrics, 1986.

Hannah Kinoshita, MD, is an oncologist in the Division of Oncology in the Center for Cancer and Blood Disorders. Her research interests include cellular immunotherapy for high-risk hematologic malignancies. Dr. Kinoshita is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. Her clinical expertise encompasses Multisystem Inflammatory Syndrome in Children (MIS-C), Acute Lymphoblastic Leukemia (ALL), Leukemia, Medulloblastoma, and Bone Marrow Transplant. Dr. Kinoshita is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2023 and American Board Of Pediatrics, 2018.

Ann Gramza is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Gramza is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Anaplastic Thyroid Cancer, Thyroid Cancer, Medullary Thyroid Carcinoma, and Laryngeal Cancer.

Lingling Liu is a primary care provider, practicing in Internal Medicine in Washington, Washington, D.c.. Dr. Liu is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Somatostatinoma, Mitochondrial Complex 2 Deficiency, Sepsis, Endoscopy, and Gastrostomy.

Sherif Shaaban is a Radiation Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Shaaban is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. His clinical expertise encompasses Olfactory Neuroblastoma, Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, and Gliomatosis Cerebri.

Caileigh Pudela is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Pudela is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. Her clinical expertise encompasses Neuroblastoma, Infantile Neutropenia, Embryonal Tumor with Multilayered Rosettes, and Immune Thrombocytopenic Purpura (ITP).

Dennis Priebat is a Hematologist practicing medicine in Washington, Washington, D.c.. Dr. Priebat is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Mesenchymoma, and Rhabdomyosarcoma Embryonal.

Tara Suntum is a primary care provider, a Hematologist and an Oncologist in Washington, Washington, D.c.. Dr. Suntum is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. Her clinical expertise encompasses Pyruvate Dehydrogenase Deficiency, DICER1 Syndrome, Metabolic Acidosis, and Neuroblastoma.

Mona Elmacken is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Elmacken is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. Her clinical expertise encompasses Ewing Sarcoma, Medulloblastoma, Osteosarcoma, Neuroblastoma, and Bone Marrow Transplant.

Wendy Fitzgerald is a Nurse Practitioner practicing medicine in Washington, Washington, D.c.. Fitzgerald, NP is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. Her clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, and Immune Thrombocytopenic Purpura (ITP).

Martha Donoghue is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Donoghue is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. Her clinical expertise encompasses PIK3CA-Related Overgrowth Spectrum, Embryonal Tumor with Multilayered Rosettes, Neuroblastoma, Glioma, and Tissue Biopsy.

Irina Veytsman is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Veytsman is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma.

Amy Hont is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Hont is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Osteosarcoma, Ewing Sarcoma, and Rhabdoid Tumor.

Corina Gonzalez is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Gonzalez is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Graft Versus Host Disease (GvHD), Infantile Neutropenia, Chronic Graft Versus Host Disease (cGvHD), X-Linked Severe Combined Immunodeficiency, and Bone Marrow Transplant.